Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations

Cardiovascular Research

Volumn 64, Issue 3, 2004, Pages 457-466

  Caballero, Ricardo ^a   Gómez, Ricardo ^a   Núñez, Lucía ^a   Moreno, Ignacio ^a   Tamargo, Juan ^a   Delpón, Eva ^a  

^a SCHOOL OF MEDICINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL L TYPE; DILTIAZEM; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM BINDING; CALCIUM CURRENT; CHO CELL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG INHIBITION; FIBROBLAST CULTURE; HEART RATE VARIABILITY; HEART SUPRAVENTRICULAR ARRHYTHMIA; IC 50; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CHO CELLS; CRICETINAE; DEPRESSION, CHEMICAL; DILTIAZEM; FEMALE; FIBROBLASTS; KV1.5 POTASSIUM CHANNEL; MICE; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, VOLTAGE-GATED; SHAL POTASSIUM CHANNELS; TRANSFECTION;

EID: 8644250552     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.07.022     Document Type: Article

References (25)

1. D.R. Abernethy, and J.B. Schwartz Calcium-antagonist drugs N. Engl. J. Med. 341 1999 1447 1457
2. S. Zhang, Z. Zhou, Q. Gong, J.C. Makielski, and C.T. January Mechanism of block and identification of the verapamil binding domain to HERG potassium channels Circ. Res. 84 1999 989 998
3. + channel cloned from human heart Mol. Pharmacol. 44 1993 642 648
4. X. Zhang, J.W. Anderson, and D. Fedida Characterization of nifedipine block of the human heart delayed rectifier, hKv1.5 J. Pharmacol. Exp. Ther. 281 1997 1247 1256
5. + channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines Mol. Pharmacol. 45 1994 1227 1234
6. S. Rolf, W. Haverkamp, M. Borggrefe, U. Musshoff, L. Eckardt, and J. Mergenthaler Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes Naunyn-Schmiedeberg's Arch. Pharmacol. 362 2000 22 31
7. U. Jahnel, P. Klemm, and H. Nawrath Different mechanisms of the inhibition of the transient outward current in rat ventricular myocytes Naunyn-Schmiedeberg's Arch. Pharmacol. 349 1994 87 94
8. + current similar to Kv1.5 cloned channel currents Circ. Res. 73 1993 1061 1076
9. D. Escande, A. Coulombe, J.F. Faivre, and E. Coraboeuf Characteristics of the time-dependent slow inward current in adult human atrial single myocytes J. Mol. Cell. Cardiol. 18 1986 547 551
10. + channel in ventricular muscle. A molecular correlate for the transient outward current Circ. Res. 79 1996 659 668
11. B. Rosati, Z. Pan, S. Lypen, H.S. Wang, I. Cohen, and J.E. Dixon Regulation of KChIP2 potassium channel beta subunit gene expression underlies the gradient of transient outward current in canine and human ventricle J. Physiol. 533 2001 119 125
12. M. Courtemanche, R.J. Ramirez, and S. Nattel Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model Am. J. Physiol. 275 1998 H301 H321
13. + currents Circulation 101 2000 1199 1205
14. R. Caballero, E. Delpon, C. Valenzuela, M. Longobardo, T. Gonzalez, and J. Tamargo Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization Mol. Pharmacol. 59 2001 825 836
15. I. Moreno, R. Caballero, T. Gonzalez, C. Arias, C. Valenzuela, and I. Iriepa Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization J. Pharmacol. Exp. Ther. 304 2003 862 873
16. M.M. Buckley, S.M. Grant, K.L. Goa, D. McTavish, and E.M. Sorkin Diltiazem. A reappraisal of its pharmacological properties and therapeutic use Drugs 39 1990 757 806
17. R. Caballero, I. Moreno, T. González, C. Valenzuela, J. Tamargo, and E. Delpón Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5) Cardiovasc. Res. 56 2002 104 117
18. + channels J. Biol. Chem. 279 2004 394 400
19. + currents Br. J. Pharmacol. 130 2000 391 401
20. T.P. Calmels, J.F. Faivre, B. Cheval, J.L. Javre, S. Rouanet, and A. Bril hKv4.3 channel characterization and regulation by calcium channel antagonists Biochem. Biophys. Res. Commun. 281 2001 452 460
21. 2+ antagonists and agonists in rabbit cardiac myocytes Am. J. Physiol. 260 1991 H1737 H1742
22. R. Caballero, M. Pourrier, G. Schram, E. Delpón, J. Tamargo, and S. Nattel Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines Br. J. Pharmacol. 138 2003 1475 1484
23. A. Benardeau, S. Fareh, and S. Nattel Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs Cardiovasc. Res. 50 2001 85 96
24. S. Fareh, A. Benardeau, and S. Nattel Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs Cardiovasc. Res. 49 2001 762 770
25. + channel function in mice: what have we learned, and where do we go from here? Circ. Res. 89 2001 944 956